Discovering differential DNA methylation patterns in alzheimer's disease and related disorders in a large population based cohort: age gene/environment susceptibility-reykjavik study (AGES-RS). Period…
Ended Purchase Order Awarded Last action
- Contract number
- 75N95021P00165
- Awardee
-
Hjartavernd SES UEI PDZAGJBZW6W6
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $983,660
Award facts
- Opportunity
-
- Discovering differential DNA methylation patterns in Alzheimer's disease and related disorders in a large population based cohort: AGES-RS Pre-Solicitation · HHSNIHNIDACSS2100290 · Posted Jan 6, 2021
- Discovering differential DNA methylation patterns in Alzheimer's disease and related disorders in a large population based cohort: Age Gene/Environment Susceptibility-Reykjavik Study (AGES-RS) Award Notice · Posted Apr 7, 2021
- Contract value 100% obligated
- $983,660.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Institute on Aging National Institutes of Health, Department of Health and Human Services
- NAICS code
- 621511 Medical Laboratories
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 3 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Iceland
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this award
This firm fixed-price purchase order for $983,660 was awarded by the National Institutes of Health's National Institute on Aging to Hjartavernd SES of Iceland. The contract calls for the contractor to analyze approximately 5,000 DNA samples from the Age Gene/Environment Susceptibility-Reykjavik Study cohort to discover differential DNA methylation patterns related to Alzheimer's disease and other disorders. Specifically, the contractor will ship samples to a compliant laboratory, provide normalized methylation data, and conduct quality control and association analyses over a one-year period of performance through April 2022. There is no set-aside designation for this award made pursuant to a solicitation seeking proposals for methylation analysis services to support the National Institute on Aging's longitudinal aging study.
Description
Discovering differential DNA methylation patterns in alzheimer's disease and related disorders in a large population based cohort: age gene/environment susceptibility-reykjavik study (AGES-RS). Period of performance: 4/12/21 to 4/11/22.
Quick answers
Who was awarded contract 75N95021P00165?
75N95021P00165 was awarded to Hjartavernd SES by National Institute on Drug Abuse (National Institutes of Health) on April 12, 2021.
How much is contract 75N95021P00165 worth?
The government has obligated $983,660 on 75N95021P00165.
Which agency awarded contract 75N95021P00165?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95021P00165, with funding from National Institute on Aging (National Institutes of Health).
Was contract 75N95021P00165 competed?
The extent of competition for 75N95021P00165 was competed under sap. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award